Ascletis gets pharmaceutical trade license and GSP certificate

Ascletis Pharma, an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and fatty liver diseases, announces today that Ascletis XinNuo Medicine (HangZhou) Co.,Ltd. (hereinafter referred to as Ascletis XinNuo), a wholly-owned subsidiary of Ascletis, has recently obtained the Pharmaceutical Trade License and GSP Certificate issued by ZheJiang Medical Products Administration. The business scope of Ascletis XinNuo composes of drug distribution, and import & export agency. It mainly covers major kinds of innovative drugs manufactured directly by Ascletis and via its business partners. With a well-established GSP quality management system, modern logistics facilities and equipment, Ascletis XinNuo has ensured the quality control of products over its drug distribution process. “Ascletis has developed into an integrated platform from drug discovery and development to manufacturing and commercialization,” said Jinzi J. Wu, PhD, Founder, Chairman and CEO of Ascletis, “ Obtaining Pharmaceutical Trade License and GSP Certificate marks another milestone in Ascletis’ commercialization layout. This has enabled Ascletis to position as the best partner within the innovative pharmaceutical industry by achieving an open and full cooperation throughout the entire industry chain. ” In the future, Ascletis will import potentially innovative medical products worldwide through Ascletis XinNuo, in order to further strengthen its product pipeline of innovative drugs. At the same time, Ascletis XinNuo will develop its international cooperation, to benefit patients in countries and regions under the Belt and Road Initiative with its global first-in-class innovative drugs.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!